1min read
PREVIOUS ARTICLE Perth to test driverless Uber ... NEXT ARTICLE Aust shares look set to open l...

Executive Series: Kazia Therapeutics (KZA) CEO & Managing Director, Dr James Garner In this short video, Tom & James discuss; • Kazia’s recent name change from Novogen
• Progress of its ovarian cancer and brain cancer drug trials YouTube Link: https://youtu.be/Pd55l3EC66A To view more Executive Series interviews, visit:https://www.commsec.com.au/market-news/executive-series